RLBAX
Price
$34.49
Change
-$0.05 (-0.14%)
Updated
May 23 closing price
Net Assets
237.69B
SVBCX
Price
$28.63
Change
-$0.08 (-0.28%)
Updated
May 23 closing price
Net Assets
5.62B
Interact to see
Advertisement

RLBAX vs SVBCX

Header iconRLBAX vs SVBCX Comparison
Open Charts RLBAX vs SVBCXBanner chart's image
American Funds American Balanced R1
Price$34.49
Change-$0.05 (-0.14%)
VolumeN/A
Net Assets237.69B
JHancock Balanced C
Price$28.63
Change-$0.08 (-0.28%)
VolumeN/A
Net Assets5.62B
RLBAX vs SVBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RLBAX vs. SVBCX commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLBAX is a Buy and SVBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 238B vs. SVBCX (5.62B). RLBAX pays higher dividends than SVBCX: RLBAX (1.28) vs SVBCX (0.92). RLBAX was incepted earlier than SVBCX: RLBAX (23 years) vs SVBCX (26 years). SVBCX (1.74) is less costly to investors than RLBAX (1.31). SVBCX is a more actively managed with annual turnover of: 67.00 vs. RLBAX (44.00). RLBAX has a lower initial minimum investment than SVBCX: RLBAX (250) vs SVBCX (1000). RLBAX annual gain was more profitable for investors over the last year : 3.94 vs. SVBCX (2.81). SVBCX return over 5 years is better than : 41.64 vs. RLBAX (33.77).
RLBAXSVBCXRLBAX / SVBCX
Total Expense Ratio1.311.7376%
Annual Report Gross Expense Ratio1.311.7475%
Fund Existence23 years26 years-
Gain YTD1.6850.578292%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets238B5.62B4,236%
Annual Yield % from dividends1.280.92139%
Returns for 1 year3.942.81140%
Returns for 3 years20.3725.6979%
Returns for 5 years33.7741.6481%
Returns for 10 years46.0957.5380%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NVLIX59.45N/A
N/A
Nuveen Winslow Large-Cap Growth ESG I
OPMCX19.00N/A
N/A
Invesco Main Street Mid Cap C
FCGSX23.07N/A
N/A
Fidelity Series Growth Company
LPFAX6.41N/A
N/A
ALPS Global Opportunity A
ITETX10.50N/A
N/A
VY® T. Rowe Price Equity Income S2